Momentum Bioscience

About:

Momentum Bioscience develops enzyme mediated amplification solutions for the rapid detection of pathogens in blood and sterile fluids.

Website: http://www.momentumbio.co.uk

Top Investors: Longwall Venture, The FSE Group, Wren Capital, London Business Angels (LBA)

Description:

Momentum Bioscience Ltd has a novel and innovative approach for the detection of infection in blood and other normally sterile body fluids. There Enzyme Mediated Amplification technology allows universal detection of viable bacteria and fungi in <2 hours vs 1-5 days with current laboratory techniques. It is the only rapid technology available that specifically measures viable organisms Momentum Bioscience Ltd is developing a suite of related technologies collectively termed Enzyme Mediated Amplification (EMA), for the rapid detection of pathogens found in blood and normally sterile fluids (NSF).